TipRanks
Ultragenyx Pharmaceutical (DE:UP0)
FRANKFURT:UP0

Compare Ultragenyx Pharmaceutical (UP0) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
€21.53
€1.27B
-2.55
-51.12%
10 Buy
10 Hold
0 Sell
Moderate Buy
Travere Therapeutics
$67.12
$5.28B
-118.76
109.57%
11 Buy
1 Hold
0 Sell
Strong Buy
Xenon
$60.42
$3.54B
-7.68
-7.02%
15 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$82.41
$2.37B
-9.27
-9.88%
11 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$71.45
$3.47B
-67.53
7.59%
9 Buy
0 Hold
0 Sell
Strong Buy
Mineralys Therapeutics, Inc.
$26.34
$1.94B
-5.21
-41.34%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UP0
Ultragenyx Pharmaceutical
12.91
-12.50
-49.19%
TVTX
Travere Therapeutics
53.44
27.24
103.97%
XENE
Xenon
36.41
-2.84
-7.24%
IRON
Disc Medicine
61.18
-9.10
-12.95%
TARS
Tarsus Pharmaceuticals
73.61
3.86
5.53%
MLYS
Mineralys Therapeutics, Inc.
22.09
-15.39
-41.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts